Linked Life Data

21610467

Source:http://linkedlifedata.com/resource/pubmed/id/21610467

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-5-25
pubmed:abstractText
Modern radiation oncology relies heavily on emerging technology. In this article, we review recent advances in target delineation as it applies to radiation treatment planning. We focus on the evidence to support methionine positron emission tomography use for target delineation in primary brain tumors, 2-deoxy-2-[(18)F] fluoro-D-glucose positron emission tomography use for target delineation for lung cancer and head and neck cancer, and the use of magnetic resonance imaging sequences for target delineation in prostate cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1540-336X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
151-4
pubmed:meshHeading
pubmed:articleTitle
Advances in imaging: target delineation.
pubmed:affiliation
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA. kurbania@med.umich.edu
pubmed:publicationType
Journal Article, Review